Cover
Cover - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2023 | Jun. 30, 2023 | |
Cover [Abstract] | ||
Entity Registrant Name | BIONEXUS GENE LAB CORP. | |
Entity Central Index Key | 0001737523 | |
Document Type | 10-K/A | |
Amendment Flag | true | |
Entity Voluntary Filers | No | |
Current Fiscal Year End Date | --12-31 | |
Entity Well Known Seasoned Issuer | No | |
Entity Small Business | true | |
Entity Shell Company | false | |
Entity Emerging Growth Company | true | |
Entity Current Reporting Status | Yes | |
Document Period End Date | Dec. 31, 2023 | |
Entity Filer Category | Non-accelerated Filer | |
Document Fiscal Period Focus | FY | |
Document Fiscal Year Focus | 2023 | |
Entity Ex Transition Period | false | |
Entity Common Stock Shares Outstanding | 17,667,663 | |
Entity Public Float | $ 66.5 | |
Document Annual Report | true | |
Document Transition Report | false | |
Document Fin Stmt Error Correction Flag | false | |
Entity File Number | 001-41750 | |
Entity Incorporation State Country Code | WY | |
Entity Tax Identification Number | 35-2604830 | |
Entity Address Address Line 1 | Unit 02, Level 10, Tower B, Avenue 3, The Vertical | |
Entity Address Address Line 2 | Business Suite II, Bangsar South | |
Entity Address Address Line 3 | 8 Jalan Kerinchi | |
Entity Address City Or Town | Kuala Lumpur | |
Entity Address Country | MY | |
Entity Address Postal Zip Code | 59200 | |
City Area Code | 307 | |
Amendment Description | This Amendment No. 1 on Form 10-K/A (the “Amendment”) amends the Annual Report on Form 10-K of BioNexus Gene Lab Corp. (the “Company”) for the fiscal year ended December 31, 2023 (the “Original Filing”). This Amendment is being filed solely to amend and restate in its entirety Part II., Item 9A. Controls and Proceduresof the Prior Filing. | |
Icfr Auditor Attestation Flag | false | |
Local Phone Number | 241 6898 | |
Security 12b Title | Common Stock, no par value | |
Trading Symbol | BGLC | |
Security Exchange Name | NASDAQ | |
Entity Interactive Data Current | Yes |